Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05521789 · ClinicalTrials.gov registry record · Phase 4
Erector Spinae Block for Thoracic Surgery
A Phase 4 study of Thoracic Cancer and Thoracic Diseases, sponsored by George Washington University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT05521789 is a Phase 4 study of Thoracic Cancer and Thoracic Diseases that is actively recruiting participants, run by George Washington University. The registered enrollment target is 70 participants, below the 344-participant average among 15 other Thoracic Cancer trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05521789, a Phase 4 study of Thoracic Cancer and Thoracic Diseases, is actively recruiting participants, sponsored by George Washington University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to determine if erector spinae injections with bolus infusions with local anesthetic decrease postsurgical pain and opioid consumption in patients undergoing pulmonary resection surgery.
Conditions Studied
Interventions
- DRUG ESB Thoracic
Study Locations (1)
District of Columbia
- The George Washington University - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2022-07-22 |
| Est. Completion | 2027-07-21 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05521789
The ClinicalTrials.gov registry entry for NCT05521789 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 344-participant average among 15 other Thoracic Cancer trials with a reported enrollment target (80% lower). The listed sponsor is George Washington University, which has 133 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Thoracic Cancer appearing as the primary indexed condition, and to 1 intervention - of which ESB Thoracic is the first listed.
NCT05521789 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.
Frequently Asked Questions
What is clinical trial NCT05521789 about?
NCT05521789 is a clinical study titled "Erector Spinae Block for Thoracic Surgery". The aim of this study is to determine if erector spinae injections with bolus infusions with local anesthetic decrease postsurgical pain and opioid consumption in patients undergoing pulmonary resection surgery.
What is the current status of trial NCT05521789?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2022-07-22. Estimated completion is 2027-07-21.
What conditions does trial NCT05521789 study?
This clinical trial studies the following conditions: Thoracic Cancer, Thoracic Diseases, Thoracic Neoplasms, Pulmonary Neoplasm, Pulmonary Cancer.
What interventions are being tested in trial NCT05521789?
The interventions under investigation include: ESB Thoracic (DRUG).
Who is sponsoring clinical trial NCT05521789?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05521789 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thoracic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
RECRUITING · NA
-
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
RECRUITING · NA
-
Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
RECRUITING
-
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
RECRUITING · Phase 1
-
SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention)
RECRUITING · NA
-
Patient-Generated Health Data Collection During Chemoradiotherapy for Lung Cancer
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.